Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Meloxicam 15mg tablets
1001010AAAAABAB
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | 49,906 |
|
Meloxicam 7.5mg tablets
1001010AAAAAAAA
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | 41,257 |
|
Meloxicam 15mg orodispersible tablets sugar free
1001010AAAAAJAJ
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | 173 |
|
Meloxicam 7.5mg orodispersible tablets sugar free
1001010AAAAAKAK
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | 149 |
|
Meloxicam 15mg suppositories
1001010AAAAACAC
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | No data available |
|
Meloxicam 15mg/5ml oral suspension
1001010AAAAAIAI
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | No data available |
|
Meloxicam 3.75mg/5ml oral suspension
1001010AAAAAGAG
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | No data available |
|
Meloxicam 7.5mg suppositories
1001010AAAAADAD
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | No data available |
|
Meloxicam 7.5mg/5ml oral suspension
1001010AAAAAHAH
|
Meloxicam | Meloxicam | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.